Interventions for twin-twin transfusion syndrome : a Cochrane review
Roberts, Devender, Gates, Simon, Kilby, Mark and Neilson, James P.. (2008) Interventions for twin-twin transfusion syndrome : a Cochrane review. Ultrasound in Obstetrics and Gynecology, Vol.31 (No.6). pp. 701-711. ISSN 0960-7692Full text not available from this repository.
Official URL: http://dx.doi.org/10.1002/uog.5328
We performed a Cochrane review to assess which of the treatments for twin-twin transfusion syndrome (TTTS) improves fetal, childhood and maternal outcomes. This article represents a version of the review which includes additional data to the published version. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (April 2007) and the Cochrane Central Register of Controlled Trials (The Cochrane Library, October 2007) for randomized and quasi-randomized studies of amnioreduction, laser coagulation and septostomy and compared their outcomes. We also searched conference proceedings and contacted the authors of published trials for clarification and addtional data. No trials compared intervention with no intervention. Three studies (253 women) were included. Laser coagulation resulted in less overall death (48% vs. 59%; relative risk (RR), 0.81; 95% CI, 0.65-1.01 adjusted for clustering; two trials, 364 fetuses), perinatal death (26% vs. 44%; RR, 0.59; 95% CI, 0.40-0.87 adjusted for clustering; one trial, 284 fetuses) and neonatal death (8% vs. 26%; RR, 0.29; 95% CI, 0.14-0.61 adjusted for clustering; one trial, 284 fetuses) when compared with amnioreduction. There was no difference in perinatal outcome between amnioreduction and septostomy. More babies were alive without neurological abnormality at the age of 6 months in the laser group than in the amnioreduction group (52% vs. 31%; RR, 1.66; 95% CI, 1.17-2.35 adjusted for clustering; one trial). There was no difference in the proportion of babies alive at 6 months that bad undergone treatment for major neurological abnormality between the laser coagulation and the amnioreduction groups (4% vs. 7%; RR, 0.58; 95% CI, 0.18-1.86 adjusted for clustering; one trial). The results suggest that endoscopic laser coagulation of anastomotic vessels should be considered in the treatment of all stages of TTTS to improve perinatal and neonatal outcome. Copyright (C) 2008 ISUOG. Published by John Wiley & Sons, Ltd.
|Item Type:||Journal Article|
R Medicine > RG Gynecology and obstetrics
|Divisions:||Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI)
Faculty of Medicine > Warwick Medical School
|Library of Congress Subject Headings (LCSH):||Systematic reviews (Medical research), Diseases in twins -- Treatment -- Research|
|Journal or Publication Title:||Ultrasound in Obstetrics and Gynecology|
|Publisher:||John Wiley & Sons Ltd.|
|Number of Pages:||11|
|Page Range:||pp. 701-711|
|Access rights to Published version:||Restricted or Subscription Access|
|References:||1. Saade GR, Belfort MA, Berry DL, Bui TH, Montgomery LD, Johnson A, O’Day M, Olson GL, Lindholm H, Garoff L, Moise KJ Jr. Amniotic septostomy for the treatment of twin oligohydramnios-polyhydramnios sequence. Fetal Diagn Ther 1998; 13: 86–93. 2. Urig MA, Clewell WH, Elliot JP. Twin-twin transfusion syndrome. Am J Obstet Gynecol 1990; 163: 1522–1526. 3. Fusi L, Gordon H. Multiple pregnancy complicated by single intrauterine death: problems and outcome with conservative management. Br J Obstet Gynaecol 1990; 97: 511–516. 4. Van Heteren CF, Nijhuis JG, Semmekrot BA, Mulders LG, van den Berg PP. Risk for surviving twin after fetal death of co-twin in twin-twin transfusion syndrome. Obstet Gynecol 1998; 92: 215–219. 5. Saunders NJ, Snijders RJM,Nicolaides KH. Therapeutic amniocentesis in twin-twin transfusion syndrome appearing in the second trimester of pregnancy. Am J Obstet Gynecol 1991; 166: 820–824. 6. Trespidi L, Boschetto C, Caravelli E, Villa L, Kusterman A, Nicolini U. Serial amniocenteses in the management of twintwin transfusion syndrome: when is it valuable? Fetal Diagn Ther 1997; 12: 15–20. 7. De Lia JE, Kuhlmann RS, Harstad TW, Cruikshank DP. Fetoscopic laser ablation of placental vessels in severe previable twin-twin transfusion syndrome. Am J Obstet Gynecol 1995; 172: 1202–1208. 8. Ville Y, Hyett J, Hecher K, Nicolaides KH. Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome. New Engl J Med 1995; 332: 224–227. 9. Ville Y, Hecher K, Gagnon A, Sebire N, Hyett J, Nicolaides KH. Endoscopic laser coagulation in the management of severe twin-twin transfusion syndrome. Br J Obstet Gynaecol 1998; 105: 446–453. 10. Roberts D, Neilson JP, Kilby M, Gates S. Interventions for the treatment of twin-twin transfusion syndrome. Cochrane Database Syst Rev 2001; Issue 1. Art. No.: CD002073. DOI: 10.1002/14651858.CD002073 pub2. 11. Higgins JPT, Green S (eds). Search strategy for identification of studies. In Cochrane Handbook for Systematic Reviews of Interventions, 4.2.6. [updated September 2006]. The Cochrane Library, Issue 4. John Wiley&Sons, Ltd: Chichester, UK, 2006; Section 3.4. 12. Clarke M, Oxman AD (eds). Cochrane Reviewer’s Handbook 4.1 (updated June 2000); Review Manager (RevMan) [Computer program], Version 4.1. The Cochrane Collaboration: Oxford, England, 2000. 13. Clarke M, Oxman AD (eds). Assessment of Study Quality. Cochrane Reviewer’s Handbook 4.1 (updated June 2000); Section 6 Review Manager (RevMan) [Computer program], Version 4.1. The Cochrane Collaboration: Oxford, England, 2000. 14. Review Manager (RevMan) 2000; 4.1 for Windows. The Cochrane Collaboration: Oxford, England. 15. Gates S, Brocklehurst P. How should randomised trial including multiple pregnancies be analysed? BJOG 2004; 111: 213–219. 16. Higgins JPT, Green S (eds). A generic inverse approach to meta analysis. In Cochrane Handbook for Systematic Reviews of Interventions, 4.2.6. [updated September 2006]. The Cochrane Library, Issue 4. John Wiley&Sons, Ltd: Chichester, UK, 2006; Section 4. 17. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. New Engl J Med 2004; 351: 136–144. 18. Senat MV, Deprest J, Boulvain M, Ville Y. Fetoscopic laser surgery versus serial amniodrainage in the management of severe twin-to-twin transfusion syndrome at midgestation. Am J Obstet Gynecol 2003; 189: S56. 19. Ville Y, for the Eurofoetus Group. Treatment of twinto- twin-transfusion syndrome. The end of a long-standing misunderstanding. Ultrasound Obstet Gynecol 2003; 22: (Suppl 1); 64 (OC241). 20. Ortqvist L, Chevret S, Bussieres L, Staraci S, Huard F, Ville Y. Long-term neurodevelopmental outcome in twin-to-twin transfusion syndrome in the Eurofetus trial. Am J Obstet Gynecol 2006; 195: (6 Suppl 1); S3. 21. Moise Jr KJ, Dorman K, Lamvu G, Saade GR, Fisk NM, Dickinson JE, Wilson RD, Gagnon A, Belfort MA, O’Shaughnessy RO, Chitkara U, Hassan SS, Johnson A, Sciscione A, Skupski D. A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol 2005; 193: 701–707. 22. Saade G, Moise K, Dorman K, Fisk N, Dickinson JE, Wilson RD. A randomized trial of septostomy versus amnioreduction in the treatment of twin oligohydramnios polyhydramnios sequence (TOPS). Am J Obstet Gynecol 2002; 187: S54. 23. Fisk N. Twin-twin transfusion syndrome: a multicentre randomised trial for the evaluation of septostomy versus serial amnioreduction for therapy. National Research Register 2000, Issue 1. 24. Crombleholme TM, Shera D, Lee H, Johnson M, D’Alton M, Porter F, Chyu J, Silver R, Abuhamad A, Saade G, Shields L, Kauffman D, Stone J, Albanese CT, Bahado-Singh R, Ball RH, Bilaniuk L, Coleman B, Farmer D, Feldstein V, Harrison MR, Hedrick H, Livingston J, Lorenz RP, Miller DA, Norton ME, PolzinWJ, Robinson JN, Rychik J, Sandberg PL, Seri I, Simon E, Simpson LL, Yedigarova L,Wilson RD, Young B. Aprospective randomized multicenter trial of amnioreduction vs. selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol 2007; 197: 396.e1–396.e9. 25. Crombleholme T, Shera D, Porter F, Lee H, Chyu J, Silver RK, Abuhamad A, Johnson M, Saade GR, D’Alton M, Shields L, Kauffman D, Stone J, Livingston J, Polzin W, Lorenz R, Young B, Miller DA, Odibo A, Rychik J, Simpson L, Feldstein V, Coleman B, Ruchelli E, Bilaniuk L, Simon E, Vohr B, Seri I. NIH sponsored prospective randomized clinical trial of amnioreduction vs selective fetoscopic laser photocoagulation for twin-twin transfusion syndrome. Am J Obstet Gynecol 2006; 195: (6 Suppl 1): S21. 26. Crombleholme T. Amnioreduction versus selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. http://www.clinicaltrials.gov/ct2/show/ NCT00345852?term=twin+twin&rank=1 [Accessed 12 April 2006]. 27. Silver R. Twin-twin transfusion trial. http://www.enh.org [Accessed 14 June 2005]. 28. Bebbington MW, Tibald E, Wilson RD, Mann SE, Huesler-Charles M, Johnson MP. Outcomes in a cohort of patients with stage 1 twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2007; 30(Suppl): 487 (OP10.04). 29. Quintero RA, Dickinson JE, Morales WJ, Bornick PW, Berm´ udez C, Cincotta R, Chan FY, Allen MH. Stage-based treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol 2003; 188: 1333–1340. 30. Grant A. Stopping clinical trials early. BMJ 2004; 329: 525–526. 31. Brocklehurst P, Elbourne D, Alfirevic Z. Role of external evidence in monitoring clinical trials: experience from a perinatal trial. BMJ 2000; 320: 995–998. 32. Doll R. The role of data monitoring committees. In Clinical Trials, Duley L, Farrell B (eds). BMJ Publishing Group: London, 2001; 97–104. 33. O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549–556.|
Actions (login required)